Use Of Genetic Testing Panels In Idiopathic Macrocephaly
Published on: August 6, 2025
Use of Genetic Testing Panels in Idiopathic Macrocephaly featured image

Introduction

Macrocephaly is a medical term describing an increased head circumference. An affected infant presents a head circumference larger than average, typically, more than two standard deviations (2SD) above the mean for their age and sex.1 

Idiopathic macrocephaly refers to cases where the head is enlarged, however, there is no clear or known cause after routine medical evaluations. Idiopathic macrocephaly can result from underlying conditions that could cause neurological deficits and developmental delays. Recognising the different causes is important for distinguishing harmless cases from those that require urgent investigation and intervention to prevent long-term complications.2 

Genetic testing panels are important because macrocephaly can be the first sign of an underlying genetic condition. Genetic testing panels can detect specific mutations that explain the cause and help to identify conditions that could impact the infant's development, behaviour, or long-term health.3 

The purpose of this article is to explore the role and effectiveness of genetic testing panels in investigating idiopathic macrocephaly and aims to highlight their value in guiding diagnosis, informing clinical decisions, and supporting early intervention.

Understanding idiopathic macrocephaly 

Macrocephaly can be caused by a variety of conditions, thus, it’s important to investigate all opinions when an infant presents with an abnormally large head. The diagnosis is usually made when the head circumference surpasses the 98th percentile of their age group.1

One common cause is benign familial macrocephaly, which occurs in families and is unrelated to underlying medical conditions. In these circumstances, the infant's head could be larger but there wouldn’t be any other symptoms.1,3 

Genetic and syndromic macrocephaly are other types of macrocephaly that could be associated with conditions such as Down's syndrome, neurofibromatosis type 1, or Sotos syndrome; these conditions usually present with additional physical traits, developmental delays, or neurological features, in addition to an enlarged head circumference.3 

There are other possible causes to consider, including hydrocephalus (a buildup of cerebrospinal fluid in the brain), brain tumours, or congenital infections. Each of these potential causes requires specific investigation and management, especially if the child shows other signs of illness or delayed development.4 

The term idiopathic macrocephaly is used when a child has a large head, however, appears otherwise healthy, with normal development, no abnormal findings on brain imaging, and no signs of a genetic syndrome based on clinical examination. In these cases, the cause of the head enlargement remains unknown after routine medical evaluations.1,2

Genetic basis of macrocephaly

Several genes and pathways are commonly implicated in macrocephaly. A common example is the PTEN mutation, which is associated with disorders including Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.5,6 These conditions involve macrocephaly along with features, such as developmental delays or increased risks of specific tumours.5 

Another gene linked to macrocephaly is NSD1, which is responsible for Sotos syndrome. Children affected by Sotos syndrome usually have rapid growth during early childhood, learning difficulties, and an increased head size.7

In terms of inheritance, these mutations can follow different patterns. Some are autosomal dominant, meaning one copy of the gene is enough to cause the condition. Others can be de novo mutations (new changes not inherited from the parents) or show mosaicism, where only some of the body’s cells carry the mutation.3,5,8

The same genetic mutation can impact affected individuals differently. Some infants may only exhibit macrocephaly, while others could present more pronounced symptoms. In cases of idiopathic macrocephaly, where no clear cause is identified through standard tests, genetic testing is beneficial because it could help detect underlying conditions early, even if the infant is asymptomatic and appears healthy otherwise.1,2,3 

Role of genetic testing panels 

Genetic testing panels provide a faster and more efficient approach to screen multiple genes at the same time. Instead of focusing on a single gene, these panels analyse a group of genes that are associated with specific diseases or conditions, helping to identify genetic mutations or variations that could explain the symptoms.4

For idiopathic macrocephaly, genetic testing plays an important role in diagnosis when used alongside clinical evaluations and brain imaging to identify any underlying causes. Some genetic conditions can start with macrocephaly, and other symptoms can develop as the infant grows and develops.2,4 Mutations in genes, such as PTEN, NSD1, and those in the PIK3CA/AKT/mTOR pathway, are associated with syndromes where macrocephaly appears as a primary or early sign.7,9 

Using genetic panel testing to identify mutations, helps clinicians diagnose or eliminate various genetic disorders more effectively than testing each gene individually. One key advantage of genetic testing panels is that they are cost-effective, as they allow multiple genomes to be tested at the same time rather than individually; this makes the process faster, more efficient, and affordable. Another key strength is the high level of accuracy and reliability through advanced sequencing technologies and carefully designed gene panels.4,9 

The inclusion of both coding and selected non-coding disease-causing variants increases the chances of identifying meaningful genetic changes, particularly in complex cases such as idiopathic macrocephaly, where the underlying cause may not be immediately obvious.4,9

Limitations of genetic testing panels

While genetic testing panels are a helpful diagnostic tool, it is essential to understand their limitations, particularly in cases like idiopathic macrocephaly where the cause is unclear. These tests might not detect all types of genetic changes, including balanced translocations, large insertions or deletions, or other mutation variants in genes located in duplicated regions.4,10 

Therefore, if a panel returns a negative result, it does not eliminate the possibility of a genetic cause. Additionally, the panels are limited to a specific set of known genes, meaning that the mutations causing diseases in other genes might be overlooked and not identified or included in the panel.4,9,10 

Additionally, the diagnostic yield of gene panels, or the chance of obtaining a useful result, can differ based on the population being tested and the particular genes that are part of the panel. Some gene variants are found more frequently in specific ethnic or regional groups, which means that panels not designed for those backgrounds may not work as well. Therefore, while gene panels are a valuable starting point in investigating idiopathic macrocephaly, their results should be interpreted alongside clinical findings, family history, and, when necessary, followed by broader genetic testing, such as whole genome sequencing to uncover less obvious causes.4,10,11

FAQs

What is idiopathic macrocephaly?

Idiopathic macrocephaly is a condition characterised by an unusually large head circumference (size) without a known cause. However, idiopathic macrocephaly is diagnosed after standard medical tests such as physical exams, brain scans, and family history assessments, and no clear cause can be identified.1,2,4

Why is genetic testing used in idiopathic macrocephaly?

Genetic testing is important because some children with idiopathic macrocephaly might have genetic mutations that standard tests do not find. Genetic panels assist in recognising hidden health issues early on, even when the child appears to be healthy.4,10

What are the benefits of using genetic panels?

Genetic panels are:10,11

  • Cost-effective
  • Faster than testing one gene at a time
  • Targeted, which reduces unnecessary or confusing findings
  • Helpful in guiding early diagnosis, monitoring, and care

What happens if the panel finds a genetic mutation?

If a mutation is found, the child may be diagnosed with a specific genetic condition. This can guide further medical care, including monitoring for other symptoms or health risks. It also helps with genetic counselling for the family.4,10,11

What are the limitations of genetic testing panels?

While helpful, panels may not detect all types of genetic changes, such as large deletions, balanced translocations, or deep non-coding variants. Additionally, panels won’t find mutations in genes that aren’t included in the panel; this means a negative result does not always rule out a genetic cause.4,10,11

Summary 

Idiopathic macrocephaly refers to a condition in which an infant has a larger than normal head size, and there is no obvious cause after routine medical examinations. It might not be harmful, however, it could indicate a genetic condition. 

Genetic testing panels are beneficial in these situations because they enable the testing of several important genes simultaneously, which boosts the likelihood of a diagnosis, particularly when the child seems healthy.

These panels are affordable, effective, and made to identify specific mutations associated with conditions such as Cowden and Sotos syndromes, which also relate to more complex symptoms and neurodevelopmental involvement. However, the panels have some limitations; they could overlook some mutations or gene changes that are not part of the panel. Therefore, the results should be considered in the context of the clinical findings and, if necessary, followed up with more extensive tests, such as whole genome sequencing.

Overall, genetic panels are an important initial approach to exploring the potential genetic factors behind a case of idiopathic macrocephaly.

References 

  1. Jones SG, Samanta D. Macrocephaly. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Aug 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560786/
  2. Long-term Outcome of Infantile Idiopathic Macrocephaly. AAP Grand Rounds [Internet]. 2007 [cited 2025 Aug 6]; 17(2):16–16. Available from: https://publications.aap.org/aapgrandrounds/article/17/2/16/88876/Long-term-Outcome-of-Infantile-Idiopathic
  3. Williams CA, Dagli A, Battaglia A. Genetic disorders associated with macrocephaly. American J of Med Genetics Pt A [Internet]. 2008 [cited 2025 Aug 6]; 146A(15):2023–37. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.32434
  4. Accogli A, Geraldo AF, Piccolo G, Riva A, Scala M, Balagura G, et al. Diagnostic Approach to Macrocephaly in Children. Front Pediatr [Internet]. 2022 [cited 2025 Aug 6]; 9:794069. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795981/
  5. Yehia L, Eng C. PTEN Hamartoma Tumor Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2025 Jul 22]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1488/.
  6. Hendriks YMC, Verhallen JTCM, Smagt JJ van der, Kant SG, Hilhorst Y, Hoefsloot L, et al. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Fam Cancer [Internet]. 2003; 2(2):79–85. Available from: https://pubmed.ncbi.nlm.nih.gov/14574156/.
  7. Türkmen S, Gillessen-Kaesbach G, Meinecke P, Albrecht B, Neumann LM, Hesse V, et al. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes. Eur J Hum Genet [Internet]. 2003 [cited 2025 Jul 22]; 11(11):858–65. Available from: https://www.nature.com/articles/5201050.
  8. Mohiuddin M, Kooy RF, Pearson CE. De novo mutations, genetic mosaicism and human disease. Front Genet [Internet]. 2022 [cited 2025 Jul 22]; 13:983668. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550265/.
  9. Yehia L, Keel E, Eng C. The Clinical Spectrum of PTEN Mutations. Annu Rev Med [Internet]. 2020 [cited 2025 Aug 6]; 71(1):103–16. Available from: https://www.annualreviews.org/doi/10.1146/annurev-med-052218-125823
  10. Lalonde E, Rentas S, Lin F, Dulik MC, Skraban CM, Spinner NB. Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution. Front Pediatr [Internet]. 2020 [cited 2025 Jul 23]; 8:373. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360789/.
  11. Chang Y-T, Hong S-Y, Lin W-D, Lin C-H, Lin S-S, Tsai F-J, et al. Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics. Children (Basel) [Internet]. 2023 [cited 2025 Jul 23]; 10(3):556. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047509/.

Share

Iqra Hassan

arrow-right